495 related articles for article (PubMed ID: 21031544)
1. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.
Tao R; Ruppert K; Cruz RJ; Malik SM; Shaikh O; Ahmad J; DiMartini A; Humar A; Fontes PA; de Vera ME
Liver Transpl; 2010 Nov; 16(11):1288-95. PubMed ID: 21031544
[TBL] [Abstract][Full Text] [Related]
2. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus.
Taner CB; Bulatao IG; Keaveny AP; Willingham DL; Pungpapong S; Perry DK; Rosser BG; Harnois DM; Aranda-Michel J; Nguyen JH
Liver Transpl; 2011 Jun; 17(6):641-9. PubMed ID: 21618684
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of severe recurrence of hepatitis C virus in liver transplant recipients of donation after cardiac death allografts.
Hernandez-Alejandro R; Croome KP; Quan D; Mawardi M; Chandok N; Dale C; McAlister V; Levstik MA; Wall W; Marotta P
Transplantation; 2011 Sep; 92(6):686-9. PubMed ID: 21832962
[TBL] [Abstract][Full Text] [Related]
4. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
[TBL] [Abstract][Full Text] [Related]
5. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of donation after cardiac death liver allografts from a single center.
Nguyen JH; Bonatti H; Dickson RC; Hewitt WR; Grewal HP; Willingham DL; Harnois DM; Schmitt TM; Machicao VI; Ghabril MS; Keaveny AP; Aranda-Michel J; Satyanarayana R; Rosser BG; Hinder RA; Steers JL; Hughes CB
Clin Transplant; 2009; 23(2):168-73. PubMed ID: 19220366
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation following donation after cardiac death: an analysis using matched pairs.
Pine JK; Aldouri A; Young AL; Davies MH; Attia M; Toogood GJ; Pollard SG; Lodge JP; Prasad KR
Liver Transpl; 2009 Sep; 15(9):1072-82. PubMed ID: 19718634
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation from donation after cardiac death: a single center experience.
Fujita S; Mizuno S; Fujikawa T; Reed AI; Kim RD; Howard RJ; Hemming AW
Transplantation; 2007 Jul; 84(1):46-9. PubMed ID: 17627236
[TBL] [Abstract][Full Text] [Related]
9. Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors.
Chan EY; Olson LC; Kisthard JA; Perkins JD; Bakthavatsalam R; Halldorson JB; Reyes JD; Larson AM; Levy AE
Liver Transpl; 2008 May; 14(5):604-10. PubMed ID: 18433032
[TBL] [Abstract][Full Text] [Related]
10. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience.
Grewal HP; Willingham DL; Nguyen J; Hewitt WR; Taner BC; Cornell D; Rosser BG; Keaveny AP; Aranda-Michel J; Satyanarayana R; Harnois D; Dickson RC; Kramer DJ; Hughes CB
Liver Transpl; 2009 Sep; 15(9):1028-35. PubMed ID: 19718636
[TBL] [Abstract][Full Text] [Related]
12. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors.
Taner CB; Bulatao IG; Willingham DL; Perry DK; Sibulesky L; Pungpapong S; Aranda-Michel J; Keaveny AP; Kramer DJ; Nguyen JH
Liver Transpl; 2012 Jan; 18(1):100-11. PubMed ID: 21837741
[TBL] [Abstract][Full Text] [Related]
13. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
Rayhill SC; Wu YM; Katz DA; Voigt MD; Labrecque DR; Kirby PA; Mitros FA; Kalil RS; Miller RA; Stolpen AH; Schmidt WN
Transplantation; 2007 Aug; 84(3):331-9. PubMed ID: 17700157
[TBL] [Abstract][Full Text] [Related]
14. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool.
Selck FW; Grossman EB; Ratner LE; Renz JF
Ann Surg; 2008 Oct; 248(4):599-607. PubMed ID: 18936573
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of hepatitis C infection after liver transplantation.
Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
[TBL] [Abstract][Full Text] [Related]
16. Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation.
Selzner M; Kashfi A; Selzner N; McCluskey S; Greig PD; Cattral MS; Levy GA; Lilly L; Renner EL; Therapondos G; Adcock LE; Grant DR; McGilvray ID
Liver Transpl; 2009 Oct; 15(10):1288-95. PubMed ID: 19790152
[TBL] [Abstract][Full Text] [Related]
17. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
[TBL] [Abstract][Full Text] [Related]
18. Similar liver transplantation survival with selected cardiac death donors and brain death donors.
Dubbeld J; Hoekstra H; Farid W; Ringers J; Porte RJ; Metselaar HJ; Baranski AG; Kazemier G; van den Berg AP; van Hoek B
Br J Surg; 2010 May; 97(5):744-53. PubMed ID: 20393979
[TBL] [Abstract][Full Text] [Related]
19. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
[TBL] [Abstract][Full Text] [Related]
20. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
Burak KW; Kremers WK; Batts KP; Wiesner RH; Rosen CB; Razonable RR; Paya CV; Charlton MR
Liver Transpl; 2002 Apr; 8(4):362-9. PubMed ID: 11965581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
